FilingReader Intelligence
Cohance Lifesciences appoints new CDMO business chief executive
July 28, 2025 at 11:09 AM UTC•By FilingReader AI
Cohance Lifesciences Limited's CDMO business chief executive Dr. Sudhir Kumar Singh will resign on July 31, 2025, due to health issues.
Mr. Yann D'Herve will replace him as chief executive of the CDMO business from August 1, 2025, and will be based in New Jersey.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:SUVENPHAR•Bombay Stock Exchange
News Alerts
Get instant email alerts when SUVEN PHARMACEUTICALS publishes news
Free account required • Unsubscribe anytime